171 related articles for article (PubMed ID: 16751656)
1. Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft.
Bestard O; Cruzado JM; Ercilla G; Gomà M; Torras J; Serón D; Rama I; Ibernon M; Viñas O; Carrera M; Grinyó JM
Nephrol Dial Transplant; 2006 Aug; 21(8):2320-4. PubMed ID: 16751656
[No Abstract] [Full Text] [Related]
2. Membranoproliferative injury pattern in a renal allograft.
Gökden N; Rossini M; Kumar J; Fogo AB
Am J Kidney Dis; 2005 Sep; 46(3):573-6. PubMed ID: 16129221
[No Abstract] [Full Text] [Related]
3. [Presence of hepatitis C virus in renal tissue in membranoproliferative glomerulonephritis and cryoglobulinemia].
Tormo A; Rivera F; Muñoz C; Trigueros M
Nefrologia; 2003; 23(2):165-8. PubMed ID: 12778882
[TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
Basse G; Ribes D; Kamar N; Mehrenberger M; Sallusto F; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
[TBL] [Abstract][Full Text] [Related]
5. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases].
Ben Fatma L; Ben Hamida F; Aoudia R; Goucha R; Kaaroud H; Béji S; Barbouch S; Hedri H; Abderrahim E; Elyounsi F; Ben Abdallah T; Ben Moussa F; Kheder A
Tunis Med; 2007 Mar; 85(3):220-4. PubMed ID: 17668578
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection and glomerular disease.
Fabrizi F; Donato F; Messa P
Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
[TBL] [Abstract][Full Text] [Related]
7. Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy.
Quartuccio L; Salvin S; Fabris M; Sacco S; De Vita S
Ann Rheum Dis; 2008 Oct; 67(10):1494-5. PubMed ID: 18791058
[No Abstract] [Full Text] [Related]
8. Treatment of hepatitis C-virus-related glomerulonephritis.
Kamar N; Rostaing L; Alric L
Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
[TBL] [Abstract][Full Text] [Related]
9. [Mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and chronic hepatitis C. Sequential treatment with immunosuppressors and interferon].
Millán Mon A; Chahin J; Romero F; Perera A
Med Clin (Barc); 1994 Jan; 102(1):34-5. PubMed ID: 8133687
[No Abstract] [Full Text] [Related]
10. [Difficulties in treatment of kidney diseases related to HCV infection].
Jabłońska J; Kozłowska J
Przegl Epidemiol; 2009; 63(1):75-8. PubMed ID: 19522231
[TBL] [Abstract][Full Text] [Related]
11. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.
Maki T; Carville A; Stillman IE; Sato K; Kodaka T; Minamimura K; Ogawa N; Kanamoto A; Gottschalk R; Monaco AP; Marr-Belvin A; Westmoreland SV; Sehgal P
Transplantation; 2008 Mar; 85(6):893-902. PubMed ID: 18360273
[TBL] [Abstract][Full Text] [Related]
12. Membranoproliferative glomerulonephritis due to Hepatitis C in renal allograft.
Al-Arrayed AS; George SM; Ratnakar KS
Saudi Med J; 2002 Jun; 23(6):743-5. PubMed ID: 12070561
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin.
Del Bello A; Guilbeau-Frugier C; Josse AG; Rostaing L; Izopet J; Kamar N
Transpl Infect Dis; 2015 Apr; 17(2):279-83. PubMed ID: 25708383
[TBL] [Abstract][Full Text] [Related]
14. Mixed cryoglobulinaemia and hepatitis C virus infection.
Grandinetti F; De Paola L; Prunesti P; Mazzitello G
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):579. PubMed ID: 9513839
[No Abstract] [Full Text] [Related]
15. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
Fabrizi F; Lunghi G; Messa P; Martin P
J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
[TBL] [Abstract][Full Text] [Related]
16. [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis].
Akiyama K; Itabashi M; Shiohira S; Tsuruta Y; Shimizu A; Kamiyama M; Ishihara M; Otsubo S; Takei T; Taneda S; Honda K; Nitta K
Nihon Jinzo Gakkai Shi; 2011; 53(5):713-8. PubMed ID: 21842606
[TBL] [Abstract][Full Text] [Related]
17. Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.
Humphries K; Darling JM; Barritt AS
Dig Dis Sci; 2014 Aug; 59(8):2007-12. PubMed ID: 24633573
[No Abstract] [Full Text] [Related]
18. Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab.
Pérez-Sáez MJ; Toledo K; Navarro MD; Lopez-Andreu M; Redondo MD; Ortega R; Pérez-Seoane C; Agüera ML; Rodríguez-Benot A; Aljama P
Transplant Proc; 2011 Dec; 43(10):4005-9. PubMed ID: 22172889
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine treatment of cryoglobulinemic glomerulonephritis.
Rosenstock JL; Stern L; Sherman WH; Appel GB; Radhakrishnan J
Am J Kidney Dis; 2002 Sep; 40(3):644-8. PubMed ID: 12200818
[TBL] [Abstract][Full Text] [Related]
20. Cryoglobulinemia and renal disease.
Alpers CE; Smith KD
Curr Opin Nephrol Hypertens; 2008 May; 17(3):243-9. PubMed ID: 18408474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
